Precision Sensorimotor Neurorehabilitation Through Personalized Stimulation Loops
Recruiting
N/A
Interventional Study
Parkinson Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 40 (estimated)
- Sponsor
- University of Zurich · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Parkinson's disease (PD) is a neurodegenerative disease that affects about 1% of the elderly population and accounts for substantial disability and health care costs.
Disability is largely driven by mobility deficits caused by impaired gait. Effective treatments are available to restore lower limb function and improve gait, but response to treatment varies greatly from patient to patient and ofte…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Idiopathic Parkinson's disease with gait and postural stability deficits
* ≥18 years of age
* United Parkinson Disease Rating Scale (UPDRS) III gait scores 1-3
* UPDRS III postural instability scores 1-3
* Prescribed rehabilitation therapy at cereneo
* Informed consent as docu…
Contacts
No contact information available.